Capricor Therapeutics (NASDAQ: CAPR) Phase 3 HOPE-3 Meets Skeletal, Cardiac Goals in DMD - Stock Titan

Capricor Therapeutics (NASDAQ: CAPR) Phase 3 HOPE-3 Meets Skeletal, Cardiac Goals in DMD  Stock Titan